KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?
- PMID: 25155780
- PMCID: PMC4288986
- DOI: 10.1002/cncr.28979
KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: a biomarker of cancer biology or a byproduct of patient selection?
Comment on
-
KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases.Cancer. 2014 Dec 15;120(24):3965-71. doi: 10.1002/cncr.28954. Epub 2014 Aug 25. Cancer. 2014. PMID: 25155157 Free PMC article.
References
-
- Nedrebo BS, Soreide K, Eriksen MT. Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer. Br J Surg. 2011;98:716–723. - PubMed
-
- Nedrebo BS, Soreide K, Eriksen MT, Kvaloy JT, Soreide JA, Korner H. Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer. Acta Oncol. 2013;52:933–940. - PubMed
-
- Grossmann I, Doornbos PM, Klaase JM, de Bock GH, Wiggers T. Changing patterns of recurrent disease in colorectal cancer. Eur J Surg Oncol. 2014;40:234–239. - PubMed
-
- Frankel TL, D'Angelica MI. Hepatic resection for colorectal metastases. J Surg Oncol. 2014;109:2–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous